EP0637961A4 - Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors. - Google Patents

Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors.

Info

Publication number
EP0637961A4
EP0637961A4 EP94909751A EP94909751A EP0637961A4 EP 0637961 A4 EP0637961 A4 EP 0637961A4 EP 94909751 A EP94909751 A EP 94909751A EP 94909751 A EP94909751 A EP 94909751A EP 0637961 A4 EP0637961 A4 EP 0637961A4
Authority
EP
European Patent Office
Prior art keywords
methods
inflammatory bowel
bowel disease
treating inflammatory
synthesis inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94909751A
Other languages
German (de)
French (fr)
Other versions
EP0637961A1 (en
Inventor
Paul J Marshall
David D Wood
Cheryl L Nickerson-Nutter
Reiner Muller-Peddinghaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of EP0637961A1 publication Critical patent/EP0637961A1/en
Publication of EP0637961A4 publication Critical patent/EP0637961A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP94909751A 1993-02-26 1994-02-18 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors. Withdrawn EP0637961A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/024,199 US5391555A (en) 1991-11-12 1993-02-26 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
US24199 1993-02-26
PCT/US1994/001889 WO1994018976A1 (en) 1993-02-26 1994-02-18 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors

Publications (2)

Publication Number Publication Date
EP0637961A1 EP0637961A1 (en) 1995-02-15
EP0637961A4 true EP0637961A4 (en) 1995-08-09

Family

ID=21819366

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94909751A Withdrawn EP0637961A4 (en) 1993-02-26 1994-02-18 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors.

Country Status (5)

Country Link
US (1) US5391555A (en)
EP (1) EP0637961A4 (en)
JP (1) JPH07506122A (en)
CA (1) CA2134328A1 (en)
WO (1) WO1994018976A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683965A5 (en) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Ftalidrazidici compounds of the class as an active substance in anti-inflammatory agents and anti-toxic.
US6145387A (en) 1997-10-21 2000-11-14 Magna-Lastic Devices, Inc Collarless circularly magnetized torque transducer and method for measuring torque using same
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6689788B1 (en) * 2000-08-25 2004-02-10 University Of Florida Method and composition for treatment of inflammatory bowel disease
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
US8575194B1 (en) 2004-08-31 2013-11-05 Jack William Schultz Treatment methods of cognitive, emotional and mental ailments and disorders
US9149472B2 (en) 2004-08-31 2015-10-06 Jack William Schultz Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
US7923014B2 (en) * 2007-02-12 2011-04-12 The Board Of Regents Of The University Of Texas System Expression and purification of HIP/PAP and uses therefor
WO2010042933A2 (en) 2008-10-10 2010-04-15 Northwestern University Inhibition and treatment of prostate cancer metastasis
US9839625B2 (en) 2014-11-06 2017-12-12 Northwestern University Inhibition of cancer cell motility

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900261A1 (en) * 1988-05-31 1989-12-07 Bayer Ag SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL-ACETIC ACID DERIVATIVES
DE3916663A1 (en) * 1989-05-23 1990-11-29 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-ACYL-SULPHONAMIDES AND CYANAMIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE4105551A1 (en) * 1991-02-22 1992-08-27 Bayer Ag 2-SUBSTITUTED CHINOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.L. WALLACE ET AL.: "Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.", GASTROENTEROLOGY, vol. 96, no. 1, pages 29 - 36 *

Also Published As

Publication number Publication date
EP0637961A1 (en) 1995-02-15
JPH07506122A (en) 1995-07-06
CA2134328A1 (en) 1994-09-01
US5391555A (en) 1995-02-21
WO1994018976A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
ZA200006577B (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors.
ZA961445B (en) Benzoyl derivatives.
HK1009440A1 (en) Benzopyran-containing compounds and method for their use.
DE69513175D1 (en) HYDRATE INHIBITION
EP0436341A3 (en) Sequential prefetch method for 1, 2 or 3 word instructions
TR199500861A2 (en) Process for the synthesis of substituted sulfoxides.
IL132145A0 (en) Methods and compositions for treating inflammatory bowel disease
ZA963694B (en) Methods for inhibiting bone loss.
NO974364L (en) hydrate inhibition
ZA965480B (en) Kappa-opiate agonists for inflammatory bowel disorders
HK1039124A1 (en) Phthalzaine derivatives phosphodiesterase 4 inhibitors.
EP0637961A4 (en) Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors.
NZ306062A (en) Medicament containing azathioprine for treating inflammatory bowel disease
ZA967313B (en) Benzoyl derivatives.
EP0834131A4 (en) Linked caches for context data search
FI963058A (en) Ejector for firearm
IT238708Y1 (en) CRANKSET FOR FURNITURE.
EP0681995A3 (en) Scale inhibition process.
ZA956992B (en) Methods for inhibiting neuronal damage.
ZA956994B (en) Methods for inhibiting endometrial cancer.
GB9410610D0 (en) Means for processing wideband signals
AU9055091A (en) Treatment for inflammatory bowel disease
BR9400216A (en) Electroseparator for peelers
KR970000345U (en) Charcoal storage furnace
EP0602994A3 (en) Corrosion inhibitor for iron-containing materials.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19941124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER CORPORATION

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BAYER CORPORATION

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19951129